Lana Medical Company (TADAWUL:9587)

Saudi Arabia · Delayed Price · Currency is SAR

2.370

-0.130 (-5.20%)

Sep 3, 2026, 1:14 PM AST

Lana Medical Company Financials Overview

Financials in millions SAR. Fiscal year is January - December.

Millions SAR. Fiscal year is Jan - Dec.

Revenue & Profits

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun '26 Jun 30, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Revenue	107.78	92.3	84.09	48.63	40.8	31.97
Revenue Growth	9.82%	9.77%	72.89%	19.20%	27.64%	-
Gross Profit	22.2	20.84	24.9	19.21	18.87	16.87
Operating Income	6.7	5.95	8.48	-0.37	6.52	7.32
Net Income	2.8	2.7	12.46	-1.93	5.49	6.59
Earnings Per Share	0.05	0.05	0.23	-0.04	0.12	0.20
EPS Growth	-76.65%	-78.36%	-	-	-39.25%	-

Revenue by Segment

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Dec '25 Dec 31, 2025	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Rental	4.56	4.56	5.26	-	-	-
Medical Waste Management	43.81	43.81	31.29	20.51	20.11	15.52
Medical Equipment	5.12	5.12	11.01	12.36	13.34	16.45
Construction	15.83	15.83	18.77	3.71	-	-
Medical Supplies	22.98	22.98	17.75	12.05	7.35	-
Total	92.3	92.3	84.09	48.63	40.8	31.97

Cash & Debt

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun '26 Jun 30, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Cash & Investments	2.84	4.53	6.35	18.75	3.3	3.52
Total Debt	42.54	29.08	15.4	11.32	7.53	8.74
Net Cash (Debt)	-39.7	-24.54	-9.05	7.43	-4.23	-5.23
Net Cash Growth	-	-	-	-	-	-
Net Cash Per Share	-0.72	-0.45	-0.17	0.16	-0.09	-0.16

Cash Flow & CapEx

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun '26 Jun 30, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Operating Cash Flow	-2.34	-5.64	0.39	1.02	5.6	-4.95
Capital Expenditures	-4.72	-4.73	-4.12	-3.45	-5.1	-7.22
Free Cash Flow	-7.07	-10.37	-3.73	-2.43	0.5	-12.17
Free Cash Flow Growth	-	-	-	-	-	-

Margins

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun '26 Jun 30, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Gross Margin	20.59%	22.57%	29.61%	39.50%	46.25%	52.76%
Operating Margin	6.22%	6.45%	10.08%	-0.76%	15.99%	22.90%
Pretax Margin	3.59%	4.06%	16.20%	-1.07%	16.23%	24.37%
Profit Margin	2.60%	2.92%	14.82%	-3.96%	13.46%	20.63%
FCF Margin	-6.55%	-11.23%	-4.43%	-5.00%	1.22%	-38.06%

Valuation

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Sep '26 Sep 6, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
PE Ratio	46.80	48.87	12.83	-	-	-
PS Ratio	1.19	1.43	1.90	2.37	-	-